📰 Genentech News
Page 205 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 9, 2023
Insider has selected promising startups from across sectors and industries that have all the markers of great success in 2023 and beyond.
February 9, 2023
Virtual Grid by Ivy honored for excellence alongside other innovators and innovations in the grid optimization category.
February 9, 2023
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that the Lattice ORAN™ solution stack was named a 2023 Edison Awards™ finalist in the commercial technology category. Lattice ORAN is a toolkit of hardwa...
February 8, 2023
The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson
February 8, 2023
Werner Baumann retiring from company after 35 years of service.
February 8, 2023
German chemical giant Bayer on Wednesday named Bill Anderson as its new CEO, following mounting pressure from activist investors urging the company to switch direction. Anderson, an American who was previously a senior executive at Swiss pharmaceuticals company Roche, will take over the reins from W ..
February 7, 2023
Palo Altos new shuttle system is almost ready to launch. Starting March 7, residents and visitors will be able to get a ride just about anywhere in town through a new service called Palo Alto Link.
February 7, 2023
The COMMODORE 2 study met its co-primary efficacy endpoints, showing crovalimab achieved disease control in people with paroxysmal nocturnal haemoglobinuria (PNH) who have not been previously treated with
February 7, 2023
07.02.2023 - OSLO, Norway, Feb. 07, 2023 (GLOBE NEWSWIRE) - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that its Chief Executive Officer, ...
February 7, 2023
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 The Michael J. Fox Foundation grant supports the development of AC Immune's first-in-class TDP-43